An experienced Corporate Director and CEO, Doug Drysdale has chaired the Board of a NASDAQ-listed company and, as CEO for the past 14 years, has built and turned around 4 pharmaceutical companies. During Doug’s 30+ years of experience in the healthcare sector, he has formed cohesive management teams, recruited board members, completed 16 corporate acquisitions across three continents and has raised around $4 billion of both public and private capital.

Find out more about Cybin here and follow Doug on LinkedIn.

Previously, Doug was Head of M&A at Actavis Group, leading 15 corporate acquisitions across three continents, between 2004 and 2008. Over this period, Doug raised approximately $3 billion of capital and managed lending syndicates including over 25 banks, to fund the company’s growth. Actavis was sold to Watson Pharmaceuticals in 2012 for EUR4.25 billion.

Discover more:

Interested in coaching services, check out Live for Yourself Consulting and Dr. Benjamin Ritter